97 related articles for article (PubMed ID: 7577588)
21. Compound heterozygosity for the Xeroderma pigmentosum complementation group A gene associated with a mild phenotype.
Negishi I; Kato G; Moriwaki S; Ishikawa O
Eur J Dermatol; 2002; 12(6):536-9. PubMed ID: 12459522
[TBL] [Abstract][Full Text] [Related]
22. Molecular studies of Japanese patients with group A xeroderma pigmentosum using polymerase chain reaction and restriction fragment length polymorphism and nonradioactive single strand conformation polymorphism analyses.
Sumitani S; Ishikawa Y; Ishikawa Y; Minami R
J Child Neurol; 1999 Mar; 14(3):168-72. PubMed ID: 10190268
[TBL] [Abstract][Full Text] [Related]
23. Clinical profile and mutation analysis of xeroderma pigmentosum in Indian patients.
Tamhankar PM; Iyer SV; Ravindran S; Gupta N; Kabra M; Nayak C; Kura M; Sanghavi S; Joshi R; Chennuri VS; Khopkar U
Indian J Dermatol Venereol Leprol; 2015; 81(1):16-22. PubMed ID: 25566891
[TBL] [Abstract][Full Text] [Related]
24. XPA gene mutations resulting in subtle truncation of protein in xeroderma pigmentosum group A patients with mild skin symptoms.
Takahashi Y; Endo Y; Sugiyama Y; Inoue S; Iijima M; Tomita Y; Kuru S; Takigawa M; Moriwaki S
J Invest Dermatol; 2010 Oct; 130(10):2481-8. PubMed ID: 20574439
[TBL] [Abstract][Full Text] [Related]
25. Genetic investigation of XPA gene: high frequency of the c.682C>T mutation in Moroccan XP patients with moderate clinical profile.
Kindil Z; Senhaji MA; Bakhchane A; Charoute H; Chihab S; Nadifi S; Barakat A
BMC Res Notes; 2017 Dec; 10(1):704. PubMed ID: 29208038
[TBL] [Abstract][Full Text] [Related]
26. Heterozygous individuals bearing a founder mutation in the XPA DNA repair gene comprise nearly 1% of the Japanese population.
Hirai Y; Kodama Y; Moriwaki S; Noda A; Cullings HM; Macphee DG; Kodama K; Mabuchi K; Kraemer KH; Land CE; Nakamura N
Mutat Res; 2006 Oct; 601(1-2):171-8. PubMed ID: 16905156
[TBL] [Abstract][Full Text] [Related]
27. Absence of DNA repair deficiency in the confirmed heterozygotes of xeroderma pigmentosum group A.
Moriwaki S; Nishigori C; Teramoto T; Tanaka T; Kore-eda S; Takebe H; Imamura S
J Invest Dermatol; 1993 Jul; 101(1):69-72. PubMed ID: 8101209
[TBL] [Abstract][Full Text] [Related]
28. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
[TBL] [Abstract][Full Text] [Related]
29. Genotype-phenotype correlation of xeroderma pigmentosum in a Chinese Han population.
Sun Z; Zhang J; Guo Y; Ni C; Liang J; Cheng R; Li M; Yao Z
Br J Dermatol; 2015 Apr; 172(4):1096-102. PubMed ID: 25256075
[TBL] [Abstract][Full Text] [Related]
30. Compound heterozygous group A xeroderma pigmentosum patient with a novel mutation and an inherited reciprocal translocation.
Maeda T; Sato K; Tanaka T; Minami H; Taguchi H; Mimaki T; Yoshikawa K
Br J Dermatol; 2000 Jul; 143(1):174-9. PubMed ID: 10886156
[TBL] [Abstract][Full Text] [Related]
31. A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa.
Soufir N; Ged C; Bourillon A; Austerlitz F; Chemin C; Stary A; Armier J; Pham D; Khadir K; Roume J; Hadj-Rabia S; Bouadjar B; Taieb A; de Verneuil H; Benchiki H; Grandchamp B; Sarasin A
J Invest Dermatol; 2010 Jun; 130(6):1537-42. PubMed ID: 20054342
[TBL] [Abstract][Full Text] [Related]
32. DNA-based prenatal diagnosis in a Chinese family with xeroderma pigmentosum group A.
Yang Y; Ding B; Wang K; Bu D; Tu P; Zhu X
Br J Dermatol; 2004 Jun; 150(6):1190-3. PubMed ID: 15214909
[TBL] [Abstract][Full Text] [Related]
33. Ultraviolet-specific mutations in p53 gene in skin tumors in xeroderma pigmentosum patients.
Sato M; Nishigori C; Zghal M; Yagi T; Takebe H
Cancer Res; 1993 Jul; 53(13):2944-6. PubMed ID: 8319200
[TBL] [Abstract][Full Text] [Related]
34. Truncated XPA protein detected in atypical group A xeroderma pigmentosum.
Mimaki T; Nitta M; Saijo M; Tachi N; Minami R; Tanaka K
Acta Paediatr; 1996 Apr; 85(4):511-3. PubMed ID: 8740317
[TBL] [Abstract][Full Text] [Related]
35. An XPA gene splicing mutation resulting in trace protein expression in an elderly patient with xeroderma pigmentosum group A without neurological abnormalities.
Takahashi Y; Endo Y; Kusaka-Kikushima A; Nakamaura S; Nakazawa Y; Ogi T; Uryu M; Tsuji G; Furue M; Moriwaki S
Br J Dermatol; 2017 Jul; 177(1):253-257. PubMed ID: 27603812
[TBL] [Abstract][Full Text] [Related]
36. Predominant neurological phenotype in a Hungarian family with two novel mutations in the XPA gene-case series.
Zádori D; Szpisjak L; Németh IB; Reisz Z; Kovacs GG; Szépfalusi N; Németh VL; Maróti Z; Tóth-Molnár E; Oláh J; Vécsei L; Klivényi P; Kalmár T
Neurol Sci; 2020 Jan; 41(1):125-129. PubMed ID: 31478152
[TBL] [Abstract][Full Text] [Related]
37. Molecular genetic analysis of 16 XP-C patients from Germany: environmental factors predominately contribute to phenotype variations.
Schäfer A; Hofmann L; Gratchev A; Laspe P; Schubert S; Schürer A; Ohlenbusch A; Tzvetkov M; Hallermann C; Reichrath J; Schön MP; Emmert S
Exp Dermatol; 2013 Jan; 22(1):24-9. PubMed ID: 23173980
[TBL] [Abstract][Full Text] [Related]
38. Identification of a primarily neurological phenotypic expression of xeroderma pigmentosum complementation group A in a Tunisian family.
Messaoud O; Ben Rekaya M; Kefi R; Chebel S; Boughammoura-Bouatay A; Bel Hadj Ali H; Gouider-Khouja N; Zili J; Frih-Ayed M; Mokhtar I; Abdelhak S; Zghal M
Br J Dermatol; 2010 Apr; 162(4):883-6. PubMed ID: 20199544
[TBL] [Abstract][Full Text] [Related]
39. Effect of XPA gene mutations on UV-induced immunostaining of PCNA in fibroblasts from xeroderma pigmentosum group A patients.
Miura M; Sasaki T
Mutat Res; 1996 Sep; 364(1):51-6. PubMed ID: 8814338
[TBL] [Abstract][Full Text] [Related]
40. c.1643_1644delTG XPC mutation is more frequent in Moroccan patients with xeroderma pigmentosum.
Senhaji MA; Abidi O; Nadifi S; Benchikhi H; Khadir K; Ben Rekaya M; Eloualid A; Messaoud O; Abdelhak S; Barakat A
Arch Dermatol Res; 2013 Jan; 305(1):53-57. PubMed ID: 23143338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]